Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists

被引：0
|
作者：
Shellie D. Ellis
Soohyun Hwang
Emily Morrow
Kim S. Kimminau
Kelly Goonan
Laurie Petty
Edward Ellerbeck
J. Brantley Thrasher
机构：
[1] University of Kansas,Department of Population Health, School of Medicine
[2] University of North Carolina Chapel Hill,Department of Health Policy and Management, School of Public Health
[3] University of Kansas,Department of Sociology
[4] University of Kansas,Department of Family Medicine, School of Medicine
[5] Independent Researcher/Consultant/Scientific Writer,undefined
[6] American Board of Urology,undefined
来源：
BMC Cancer | / 21卷
关键词：
Active surveillance; Prostate cancer; Adoption; Barriers; Low-risk disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Katsuyoshi Hashine
    Hiroyuki Iio
    Yoshiteru Ueno
    Shohei Tsukimori
    Iku Ninomiya
    International Journal of Clinical Oncology, 2014, 19 : 531 - 535
  • [42] Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer
    Hashine, Katsuyoshi
    Iio, Hiroyuki
    Ueno, Yoshiteru
    Tsukimori, Shohei
    Ninomiya, Iku
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (03) : 531 - 535
  • [43] PHYSICIANS' PERCEPTIONS OF RECOMMENDING ACTIVE SURVEILLANCE FOR MEN WITH LOW-RISK PROSTATE CANCER: A QUALITATIVE STUDY
    Hagerman, Charlotte
    Davis, Kimberly M.
    Bellini, Paula
    Leigh, Daniel
    Zinar, Riley
    Van Den Eeden, Stephen K.
    Hoffman, Richard
    Leimpeter, Amethyst
    Taylor, Kathryn
    ANNALS OF BEHAVIORAL MEDICINE, 2016, 50 : S297 - S297
  • [44] Why men with a low-risk prostate cancer select and stay on active surveillance: A qualitative study
    Seaman, Aaron T.
    Taylor, Kathryn L.
    Davis, Kimberly
    Nepple, Kenneth G.
    Lynch, John H.
    Oberle, Anthony D.
    Hall, Ingrid J.
    Volk, Robert J.
    Reisinger, Heather Schacht
    Hoffman, Richard M.
    PLOS ONE, 2019, 14 (11):
  • [45] Active Surveillance for Prostate Cancer: Barriers to Widespread Adoption
    Sandhu, Gurdarshan S.
    Andriole, Gerald L.
    EUROPEAN UROLOGY, 2012, 62 (06) : 984 - 985
  • [46] Analysis of expanded criteria to select candidates for active surveillance of low-risk prostate cancer
    Jo, Jung Ki
    Lee, Han Sol
    Lee, Young Ik
    Lee, Sang Eun
    Hong, Sung Kyu
    ASIAN JOURNAL OF ANDROLOGY, 2015, 17 (02) : 248 - 252
  • [47] Retrospective analysis of the uptake of active surveillance for low-risk prostate cancer in Zurich, Switzerland
    Poyet, Cedric
    Scherer, Thomas Paul
    Kunz, Mirjam
    Wanner, Miriam
    Korol, Dimitri
    Rizzi, Gianluca
    Kaufmann, Basil
    Rohrmann, Sabine
    Hermanns, Thomas
    SWISS MEDICAL WEEKLY, 2023, 153
  • [48] Patient perspectives on factors influencing active surveillance adherence for low-risk prostate cancer: A qualitative study
    Subramanian, Lalita
    Hawley, Sarah T.
    Skolarus, Ted A.
    Rankin, Aaron
    Fetters, Michael D.
    Witzke, Karla
    Chen, Jason
    Radhakrishnan, Archana
    CANCER MEDICINE, 2024, 13 (01):
  • [49] Active Surveillance for Low-risk Prostate Cancer: Are All Criteria Similar?
    Cimino, Sebastiano
    Privitera, Salvatore
    Favilla, Vincenzo
    Cantiello, Francesco
    Manno, Stefano
    Cicione, Antonio
    Damiano, Rocco
    Russo, Giorgio Ivan
    Morgia, Giuseppe
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (07) : 958 - 963
  • [50] Physician Payment Incentives and Active Surveillance in Low-Risk Prostate Cancer
    Srivastava, Arnav
    Kaufman, Samuel R.
    Shay, Addison
    Oerline, Mary
    Liu, Xiu
    Van Til, Monica
    Linsell, Susan
    Labardee, Corinne
    Dall, Christopher
    Faraj, Kassem S.
    Maganty, Avinash
    Borza, Tudor
    Ginsburg, Kevin
    Hollenbeck, Brent K.
    Shahinian, Vahakn B.
    JAMA NETWORK OPEN, 2025, 8 (01)
12345